SI1761553T1 - S tumorjem povezani peptidi, ki se veĹľejo na MHC molekule - Google Patents

S tumorjem povezani peptidi, ki se veĹľejo na MHC molekule

Info

Publication number
SI1761553T1
SI1761553T1 SI200530870T SI200530870T SI1761553T1 SI 1761553 T1 SI1761553 T1 SI 1761553T1 SI 200530870 T SI200530870 T SI 200530870T SI 200530870 T SI200530870 T SI 200530870T SI 1761553 T1 SI1761553 T1 SI 1761553T1
Authority
SI
Slovenia
Prior art keywords
amino acid
mhc
tumor
given
peptide
Prior art date
Application number
SI200530870T
Other languages
English (en)
Inventor
Toni Weinschenk
Claudia Lemmel
Hans-Georg Rammensee
Stefan Stevanovic
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of SI1761553T1 publication Critical patent/SI1761553T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SI200530870T 2004-05-25 2005-05-24 S tumorjem povezani peptidi, ki se veĹľejo na MHC molekule SI1761553T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004026135A DE102004026135A1 (de) 2004-05-25 2004-05-25 An MHC-Moleküle bindende Tumor-assoziierte Peptide
EP05752606A EP1761553B1 (de) 2004-05-25 2005-05-24 An mhc-moleküle bindende tumor-assoziierte peptide

Publications (1)

Publication Number Publication Date
SI1761553T1 true SI1761553T1 (sl) 2010-01-29

Family

ID=34970615

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200530870T SI1761553T1 (sl) 2004-05-25 2005-05-24 S tumorjem povezani peptidi, ki se veĹľejo na MHC molekule
SI200531543T SI2058323T1 (sl) 2004-05-25 2005-05-24 S tumorjem povezani peptidi, ki se veĹľejo na molekule MHC

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200531543T SI2058323T1 (sl) 2004-05-25 2005-05-24 S tumorjem povezani peptidi, ki se veĹľejo na molekule MHC

Country Status (14)

Country Link
US (2) US8008431B2 (sl)
EP (2) EP1761553B1 (sl)
JP (2) JP4764874B2 (sl)
AT (1) ATE446310T1 (sl)
AU (1) AU2005247598B2 (sl)
CA (2) CA2777821C (sl)
CY (2) CY1109672T1 (sl)
DE (2) DE102004026135A1 (sl)
DK (2) DK1761553T3 (sl)
ES (2) ES2333804T3 (sl)
PL (2) PL2058323T3 (sl)
PT (2) PT1761553E (sl)
SI (2) SI1761553T1 (sl)
WO (1) WO2005116051A2 (sl)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004213A1 (en) * 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP3023436A1 (en) 2007-07-03 2016-05-25 Dako Denmark A/S Improved methods for generation, labeling and use of mhc multimers
US8080634B2 (en) * 2007-07-27 2011-12-20 Immatics Biotechnologies Gmbh Immunogenic epitope for immunotherapy
AU2012216641B2 (en) * 2007-07-27 2015-02-05 Immatics Biotechnologies Gmbh Novel immunogenic epitopes for immunotherapy
CA2694808C (en) 2007-07-27 2015-10-13 Immatics Biotechnologies Gmbh Novel immunotherapy against neuronal and brain tumors
EP2197908A2 (en) 2007-09-27 2010-06-23 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
WO2009054470A1 (ja) * 2007-10-25 2009-04-30 Toray Industries, Inc. 免疫誘導剤及びその用途
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
PL2105501T3 (pl) * 2008-03-27 2016-03-31 Immatics Biotechnologies Gmbh Innowacyjna immunoterapia przeciwko nowotworom neuronów i mózgu
DK2113253T3 (da) * 2008-04-30 2010-07-19 Immatics Biotechnologies Gmbh Ny sammensætning af tumorassocierede peptider, der bindes til humant leukocyt-antigen (HLA) klasse I eller II molekyler, til vaccinebrug
DK2119726T5 (en) 2008-05-14 2018-03-26 Immatics Biotechnologies Gmbh Novel and powerful MHC class II peptides derived from survivin and neurocan
TW201000115A (en) * 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
KR102009241B1 (ko) * 2008-08-05 2019-08-09 도레이 카부시키가이샤 면역 유도제
CN102170907A (zh) 2008-08-05 2011-08-31 东丽株式会社 用于治疗和预防癌症的药物组合物
DK2733492T3 (en) 2008-08-05 2016-04-25 Toray Industries Method for detection of cancer
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
DK2172211T3 (en) * 2008-10-01 2015-02-16 Immatics Biotechnologies Gmbh Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
AU2016204711B2 (en) * 2008-10-01 2018-03-01 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors including neuronal and brain tumors
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010117010A1 (ja) 2009-04-10 2010-10-14 北海道公立大学法人札幌医科大学 腫瘍マーカーおよびその利用
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells
MX340015B (es) 2010-02-04 2016-06-22 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
PT2532367T (pt) 2010-02-04 2018-11-09 Toray Industries Agente farmacêutico para o tratamento e/ou prevenção do cancro
CA2788547C (en) 2010-02-04 2018-06-05 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
US9115200B2 (en) 2010-02-04 2015-08-25 Toray Industries, Inc. Pharmaceutical composition for treating cancer using a monoclonal antibody having immunological reactivity with CAPRIN-1
BR112012018948B1 (pt) 2010-02-04 2021-12-14 Toray Industries, Inc Composições farmacêuticas, anticorpos, combinação farmacêutica, usos de uma composição farmacêutica, uso de um anticorpo e uso de uma combinação farmacêutica
CA2788716C (en) 2010-02-04 2019-06-18 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
GB201009222D0 (en) * 2010-06-02 2010-07-21 Immatics Biotechnologies Gmbh Improved cancer therapy based on tumour associated antigens derived from cyclin D1
IT1400874B1 (it) * 2010-07-05 2013-07-02 Univ Degli Studi Genova Supporto planare avente una superficie ultrapiatta e dispositivo per la rivelazione di antigeni comprendente detto supporto planare.
MY170949A (en) * 2011-07-11 2019-09-20 Cancer Res Initiatives Foundation A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine
US9273130B2 (en) 2012-02-21 2016-03-01 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
DE102012105193B4 (de) * 2012-06-15 2014-04-03 Eberhard-Karls-Universität Tübingen Universitätsklinikum Stimulation der zellulären Immunantwort gegen das Epstein-Barr-Virus (EBV)
CN104497123B (zh) * 2013-12-23 2017-10-27 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
CN104497125B (zh) * 2013-12-23 2018-04-27 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
CN104497124B (zh) * 2013-12-23 2017-10-03 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
GB201505585D0 (en) * 2015-03-31 2015-05-13 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
GB201511546D0 (en) 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
MA42294B1 (fr) 2015-07-01 2020-11-30 Immatics Biotechnologies Gmbh Nouveaux peptides et combinaison de peptides à utiliser en immunothérapie contre le cancer de l'ovaire et d'autres cancers
MY189596A (en) * 2015-07-15 2022-02-18 Immatics Biotechnologies Gmbh A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
GB201512733D0 (en) * 2015-07-20 2015-08-26 Genagon Therapeutics Ab Therapeutic agents for treating conditions associated with elevated GDF15
CN105859865B (zh) * 2016-05-05 2019-07-05 南方医科大学 一种基于Eps8-EGFR结合域的双重抗肿瘤多肽
CN106645677B (zh) * 2016-11-15 2019-08-09 恒瑞源正（上海）生物科技有限公司 体外检测肿瘤新生抗原特异性t细胞的方法、试剂盒以及肿瘤疫苗
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
EP4317432A3 (en) 2016-12-08 2024-04-17 Immatics Biotechnologies GmbH T cell receptors with improved pairing
GB201700567D0 (en) 2017-01-12 2017-03-01 Genagon Therapeutics Ab Therapeutic agents
CN114207675A (zh) 2019-05-28 2022-03-18 佩治人工智能公司 用于数字病理学的用于处理图像以针对所处理的图像制备载片的系统和方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US5955314A (en) * 1996-11-08 1999-09-21 Incyte Pharmaceuticals, Inc. Regulator of cell signaling
US6255055B1 (en) * 1998-03-09 2001-07-03 Wisconsin Alumni Research Foundation c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence
US7198920B1 (en) * 1999-01-29 2007-04-03 Corika Corporation HER-2/neu fusion proteins
US6274362B1 (en) * 1999-02-04 2001-08-14 Millennium Pharmaceuticals, Inc. RGS-containing molecules and uses thereof
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
JP4097178B2 (ja) * 2000-10-03 2008-06-11 株式会社グリーンペプタイド 腫瘍抗原
US7009040B2 (en) * 2003-01-21 2006-03-07 Arius Research, Inc. Cancerous disease modifying antibodies
WO2002057420A2 (en) * 2001-01-18 2002-07-25 Human Genome Sciences, Inc. 50 human secreted proteins
AU2002311787A1 (en) * 2001-03-28 2002-10-15 Zycos Inc. Translational profiling
DE10225144A1 (de) * 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
AU2003258134A1 (en) * 2002-08-09 2004-02-25 Applera Corporation Lung cancer target proteins and use thereof
CA2500687A1 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2004031210A2 (en) * 2002-10-03 2004-04-15 Epimmune Inc. Optimized multi-epitope constructs and uses thereof
US7468254B2 (en) * 2003-01-21 2008-12-23 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP

Also Published As

Publication number Publication date
PT1761553E (pt) 2009-12-22
ES2385532T3 (es) 2012-07-26
PL1761553T3 (pl) 2010-07-30
AU2011202473A1 (en) 2011-06-16
PL2058323T3 (pl) 2012-09-28
CA2777821A1 (en) 2005-12-08
ATE446310T1 (de) 2009-11-15
CA2777821C (en) 2015-09-22
EP1761553A2 (de) 2007-03-14
JP2008500033A (ja) 2008-01-10
AU2005247598A1 (en) 2005-12-08
EP2058323A1 (de) 2009-05-13
US20100021441A1 (en) 2010-01-28
US8242239B2 (en) 2012-08-14
ES2333804T3 (es) 2010-03-01
JP5182770B2 (ja) 2013-04-17
DK1761553T3 (da) 2010-02-01
EP2058323B1 (de) 2012-05-16
WO2005116051A2 (de) 2005-12-08
EP1761553B1 (de) 2009-10-21
CY1109672T1 (el) 2014-08-13
US8008431B2 (en) 2011-08-30
AU2005247598B2 (en) 2011-06-02
PT2058323E (pt) 2012-07-10
SI2058323T1 (sl) 2012-08-31
CY1112984T1 (el) 2016-04-13
JP4764874B2 (ja) 2011-09-07
US20100029573A1 (en) 2010-02-04
DE502005008379D1 (de) 2009-12-03
DE102004026135A1 (de) 2006-01-05
DK2058323T3 (da) 2012-08-06
WO2005116051A3 (de) 2006-03-02
JP2011224007A (ja) 2011-11-10
CA2568254A1 (en) 2005-12-08
CA2568254C (en) 2016-04-19

Similar Documents

Publication Publication Date Title
PL1761553T3 (pl) Peptydy charakterystyczne dla nowotworów, wiążące się z cząsteczkami MHC
UA98295C2 (ru) Опухолево-ассоциированный пептид, который неспецифически связывается с молекулами ii класса лейкоцитарного антигена человека (hla)
IL186802A0 (en) Oxyntomodulin analogues and compositions containing the same
MXPA06003474A (es) Agonistas de receptores de melanocortina.
NO20063026L (no) Antistoffer
MXPA04008077A (es) Anticuerpos ant-a° y su uso.
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
CO6150201A2 (es) Anticuerpo humanizado contra beta amiloide
HK1121768A1 (en) A method for the mass production of immunoglobulin fc region deleted initial methionine residues
WO2009004054A8 (en) A cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide
JP2005520490A5 (sl)
WO2006075253A3 (en) Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
EP1982992A4 (en) HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR
WO2005059131A3 (en) Protein binding miniature proteins and uses thereof
EP1842911A4 (en) HLA BINDING PEPTIDES, FOR THOSE CODING DNA FRAGMENTS AND RECOMBINANT VECTORS
WO2005072766A3 (en) Peptides that bind to hsp90 proteins
PT1551977E (pt) Activação local, selectiva, de membros da família de ligandos tnf de proteínas de fusão de ligando tnf nãoanticorpo, sistemicamente inactivas
EP1757687A4 (en) HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR
WO2004085461A3 (de) An mhc-moleküle bindende tumor-assoziierte peptide
WO2007066018A3 (fr) Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του
MY150639A (en) T cell adhesion molecule and antibody thereto
NZ593086A (en) Isolated peptide binding to human leukocyte antigen (HLA) and having cytotoxic T lymphocyte (CTL) inducibility
WO2009032133A3 (en) Methods and intermediates for chemical synthesis of polypeptides and proteins
EP1568775A4 (en) CANCER ASSOCIATED GEN